The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Alkeran 2 mg Film-coated Tablets

Aspen Pharma Trading LimitedPA1691/004/002

Main Information

Trade NameAlkeran 2 mg Film-coated Tablets
Active SubstancesMelphalan
Dosage FormFilm-coated tablet
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/004/002

Group Information

ATC CodeL01AA Nitrogen mustard analogues
L01AA03 melphalan


License statusAuthorised
Licence Issued01/04/1979
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back